Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain - An in vivo microdialysis study

European Journal of Pharmacology

Volumn 351, Issue 2, 1998, Pages 181-188

  Tani, Yoshihiro ^a   Saito, Kyoshi ^a   Imoto, Masahiro ^a   Ohno, Tomochika ^a  

^a SUNTORY LTD   (Japan)

Author keywords

ABT 418; Acetylcholine release; Brain; Dihydro erythroidine; GTS 21; Methyllycaconitine; Microdialysis; Nicotinic receptor; Rat

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; 3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; ACETYLCHOLINE; ALKALOID; CYTISINE; DIHYDRO BETA ERYTHROIDINE; HEXAMETHONIUM; LOBELINE; MECAMYLAMINE; NICOTINE; NICOTINIC RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; FRONTAL CORTEX; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ALKALOIDS; ANIMALS; AZOCINES; BRAIN; COTININE; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; LIGANDS; LOBELINE; MALE; MECAMYLAMINE; MICRODIALYSIS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PREFRONTAL CORTEX; QUINOLIZINES; RATS; RATS, INBRED F344; RECEPTORS, NICOTINIC; VISUAL CORTEX;

EID: 0031809369     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00314-8     Document Type: Article

References (47)

1. Alkondon, M., Albuquerque, E.X., 1993. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265, 1455-1473.
2. Alkondon, M., Pereira, E.F.R., Wonnacott, S., Albuquerque, E.X., 1992. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific antagonist. Mol. Pharmacol. 41, 802-808.
3. Anand, R., Conroy, W.G., Schoepfer, R., Whiting, P., Lindstrom, J., 1991. Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J. Biol. Chem. 226, 11192-11198.
4. 3H]methylcarbamylcholine in rat brain. Eur. J. Pharmacol. 253, 261-267.
5. 3H]methylcarbamylcholine binding sites and effect of N-ethylcarbamylcholine on acetylcholine release in rat brain. J. Neurochem. 51, 292-299.
6. Araujo, D.M., Lapchak, P.A., Robitaille, Y., Gauthier, S., Quirion, R., 1988b. Differential alternation of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J. Neurochem. 50, 1914-1923.
7. Arendash, G.W., Sengstock, G.J., Sanberg, P.R., Kern, R., 1995. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res. 674, 252-259.
8. Arneric, S.P., Sullivan, J.P., Briggs, C.A., Donnelly-Roberts, D., Anderson, D.J., Raszkiewiez, J.L., Huges, M.L., Cadman, E.D., Adams, P., Garvey, D.S., Wasicak, J.T., Williams, M., 1994. (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. J. Pharm. Exp. Ther. 270, 310-318.
9. Boulter, J., Connolly, J., Deneris, E., Goldman, D., Heinemann, S., Patrick, J., 1987. Functional expression of two neural nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc. Natl. Acad. Sci. USA 84, 7763-7767.
10. Bowen, D.M., Smith, C.B., White, P., Davison, A.N., 1976. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99, 459-496.
11. Brioni, J.D., O'Neill, A.B., Kim, D.J.B., Decker, M.W., 1993. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plusmaze test. Eur. J. Pharmacol. 238, 1-8.
12. Brioni, J.D., Morgan, S.J., O'Neill, A.B., Sykora, T.M., Postl, S.P., Pan, J.B., Sullivan, J.P., Arneric, S.P., 1996. 'In vivo' profile of novel nicotinic ligands with CNS selectivity. Med. Chem. Res., 487-510.
13. Court, J.A., Perry, E.K., Spurden, D., Lloyd, S., Gillespie, J.I., Whiting, P., Barlow, R., 1994. Comparison of the binding of nicotinic agonists to receptors from human and rat cerebral cortex and from chick brain (α4β2) transfected into mouse fibroblasts with ion channel activity. Brain Res. 667, 118-122.
14. Cooper, E., Coutupier, S., Ballivet, M., 1991. Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350, 235-238.
15. Couturier, S., Erkman, L., Valera, S., Rungger, D., Bertrand, S., Boulter, J., Ballivet, M., Bertrand, D., 1990. α5, α3 and non-α3: three clustered avian genes encoding neuronal nicotinic acetylcholine receptor related subunits. J. Biol. Chem. 265, 17560-17567.
16. Decker, M.W., Brioni, J.D., Sullivan, J.P., Buckley, M.J., Radek, R.J., Raszkiewiez, J.L., Kang, L.H., Kim, D.J.B., Giardina, W.J., Wasicak, J.T., Garvey, D.S., Williams, M., Arneric, S.P., 1994. (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vitro characterization. J. Pharm. Exp. Ther. 270, 319-328.
17. Decker, M.W., Brioni, J.D., Bannon, A.W., Arneric, S.P., 1995. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. Life Sci. 56, 545-570.
18. Elgoyhen, A.B., Johnson, D.S., Boulter, J., Vetter, D.E., Heinemann, S., 1994. α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79, 705-715.
19. Flores, C.M., Rogers, S.W., Pabreza, L.A., Wolfe, B.B., Kellar, K.J., 1992. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol. 41, 31-37.
20. Garvey, D.S., Wasicak, J., Decker, M.W., Brioni, J.D., Sullivan, J.P., Carrera, G.M., Holladay, M.H., Arneric, S.P., Williams, M., 1994. Novel isoxazoles which interact with brain cholinergic channel receptors that have intrinsic cognitive enhancing and anxiolytic activities. J. Med. Chem. 37, 1055-1059.
21. Gerzanich, V., Anand, R., Lindstrom, J., 1994. Homomers of alpha 8 and alpha 7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol. Pharmacol. 45, 212-220.
22. Hunter, B.E., deFiebre, L.M., Papke, R.L., Kem, W.R., Meyer, E.M., 1994. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 168, 130-134.
23. Jones, G.M.M., Sahakian, B.J., Levy, R., Warburnton, D.M., Gray, J.A., 1992. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108, 485-494.
24. Kihara, T., Shimohama, S., Sawada, H., Kimura, J., Kume, T., Kochiyama, H., Maeda, T., Akaike, A., 1997. Nicotinic receptor stimulation protects neurons against β-amyloid toxicity. Ann. Neurol. 42, 159-163.
25. 3H]methylcarbamylcholine binding site in rat brain. J. Neurochem. 52, 483-491.
26. Levin, E.D., 1992. Nicotinic systems and cognitive function. Psychopharmacology 108, 417-431.
27. Luetje, C.W., Patrick, J.W., 1989. Members of the neuronal nicotinic acetylcholine receptor family display distinct pharmacological and toxicological properties. Soc. Neurosci. Abstr. 15, 677.
28. Marks, M.J., Farnham, D.A., Grady, S.R., Collins, A.C., 1993. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 264, 542-552.
29. Martin, J.E., Panickar, K.S., King, M.A., Deyrup, M., Hunter, B.E., Wang, G., Meyer, E.M., 1994. Cytoprotective actions of 2,4-dimethoxy-benzylidene anabaseine in differentiated PC12 cells and septal cholinergic neurons. Drug Dev. Res. 31, 135-141.
30. Meyer, E.M., deFiebre, C.M., Hunter, B.E., Simpkins, C.E., Fraumorth, N., deFiebre, N.E.C., 1994. Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev. Res. 31, 127-134.
31. Nef, P., Oneyser, C., Alliod, C., Couturier, S., Ballivet, M., 1988. Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors. EMBO J. 7, 595-601.
32. Newhouse, P.A., Sunderland, T., Thompson, K., Tariot, P.N., Weingartner, H., Mueller, E.R., Cohen, R.M., Murphy, D.L., 1986. Intravenous nicotine in patient with Alzheimer's disease. Am. J. Psychiatry 143, 1494-1495.
33. Newhouse, P.A., Potter, A., Corwin, J., Lenox, R., 1994. Age-related effects of the nicotine antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology 10, 93-107.
34. Papke, R.L., Heinemann, S.F., 1994. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the β2 subunit. Mol. Pharmacol. 45, 142-149.
35. Paxinos, G., Watson, C., 1986. The rat brain in stereotaxic coordinates. Academic Press, New York, NY.
36. Price, D.L., 1986. New perspectives on Alzheimer's disease. Annu. Rev. Neurosci. 9, 489-512.
37. 3H]acetylcholine release from mouse cerebral cortical synaptosomes. J. Neurochem. 43, 1593-1598.
38. Sacaan, A.I., Dunlop, J.L., Lloyd, G.K., 1995. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274, 224-230.
39. Sahakian, B., Jones, G., Levy, R., Gray, J., Warburton, D., 1989. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer's type. Br. J. Psychiatry 154, 797-800.
40. Sargent, P.B., 1993. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16, 403-443.
41. Summers, K.L., Giacobini, E., 1995. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine and serotonin in rat cortex. Neurochem. Res. 20, 753-759.
42. Summers, K.L., Cuadra, G., Naritoku, D., Giacobini, E., 1994. Effects of nicotine on levels of acetylcholine and biogenic amines in rat cortex. Drug Dev. Res. 31, 108-119.
43. Tani, Y., Saito, K., Tsuneyoshi, A., Imoto, M., Ohno, T., 1997. Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice. Psychopharmacology 129, 225-232.
44. Wada, K., Ballivet, M., Boulter, J., Connolly, J., Wada, E., Deneris, E., Swanson, L., Heinemann, S., Patrick, J., 1988. Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptors. Science 240, 330-334.
45. Wilkie, G.I., Stephens, M.W., Hutson, P.J., Whiting, P., Wonnacott, S., 1993. Hippocampal nicotinic autoreceptors modulate acetylcholine release. Biochem. Soc. Trans. 21, 429-431.
46. Wilkie, G.I., Hutson, P., Sulliven, J.P., Wonnacott, S., 1996. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem. Res. 21, 1141-1148.
47. Zoltewicz, J.A., Prokai-Tatyai, K., Bloom, L.B., Kem, W.R., 1993. Long range transmission of polar effects in cholinergic 3-arylidene anabaseines. Conformations calculated by molecular modeling. Heterocyclics 35, 171-179.